But this year, the birthday of Medicaid and Medicare is more an occasion for worry than celebration. Recent changes signed ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The Trump administration is reportedly considering a way to ease Medicare and Medicaid into covering GLP-1 drugs like Ozempic ...

Several companies, including Oracle and Microsoft, are expected to sign pledges to work on the Trump administration ...

Republicans lambasted Democrats last year for subsidizing monthly payments that seniors pay for prescription drug insurance, ...

Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) traded higher in the premarket on Friday after The Washington ...

Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...